⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL903825 | 1.00 | — | — | |
| SCHEMBL803932 | 1.00 | — | — | |
| SCHEMBL27515856 | 0.85 | — | — | |
| SCHEMBL473650 | 0.82 | — | — | |
| SCHEMBL23054151 | 0.81 | TDP1 (0.39) | — | |
| SCHEMBL10040056 | 0.81 | HSD17B10 (0.36) | — | |
| SCHEMBL10667063 | 0.81 | LMNA (0.36) | — | |
| SCHEMBL14066275 | 0.81 | HSD17B10 (0.36) | — | |
| SCHEMBL20989683 | 0.79 | HSD17B10 (0.34) | — | |
| SCHEMBL12743737 | 0.79 | HSD17B10 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043047-B2 | Process for producing dichroic security features for securing value documents | SICPA HOLDING SA (CH) | 2024-07-23 | — | — | US | disclosed |
| US-20240209223-A1 | CATIONIC UV-LED RADIATION CURABLE PROTECTIVE VARNISHES FOR SECURITY DOCUMENTS | SICPA HOLDING SA (CH) | 2024-06-27 | — | — | US | disclosed |
| US-20240018378-A1 | UV-VIS RADIATION CURABLE SECURITY INKS FOR PRODUCING DICHROIC SECURITY FEATURES | SICPA HOLDING SA (CH) | 2024-01-18 | — | — | US | disclosed |
| US-20230166551-A1 | PROCESS FOR PRODUCING DICHROIC SECURITY FEATURES FOR SECURING VALUE DOCUMENTS | SICPA HOLDING SA (CH) | 2023-06-01 | — | — | US | disclosed |
| US-20170362184-A1 | PRO-SURVIVAL COMPOUNDS | HERIOT-WATT UNIVERSITY (GB) | 2017-12-21 | — | — | US | disclosed |
| US-9809585-B2 | Fluorinated 2-arylbenzo heterocyclic compound with high affinity to Aβ 946; plaques and containing chiral side chain substituent, and preparation method and usage thereof | BEIJING ZHIBO BIO-MEDICAL TECHNOLOGY CO., LTD (CN) | 2017-11-07 | — | — | US | disclosed |
| WO-2017182495-A1 | INDAZOLE DERIVATIVES THAT DOWN-REGULATE THE ESTROGEN RECEPTOR AND POSSESS ANTI-CANCER ACTIVITY | ASTRAZENECA AB (SE) | 2017-10-26 | — | — | WO | disclosed |
| US-20170305909-A1 | CHEMICAL COMPOUNDS | ASTRAZENECA UK LIMITED (GB) | 2017-10-26 | — | — | US | disclosed |
| EP-2695608-B1 | Lipid containing formulations | ARBUTUS BIOPHARMA CORP (CA) | 2016-11-23 | — | — | EP | disclosed |
| US-20160207910-A1 | Fluorinated 2-arylbenzo heterocyclic compound with high affinity to A beta 946; plaques and containing chiral side chain substituent, and preparation method and usage thereof | BEIJING ZHIBO BIO-MEDICAL TECHNOLOGY CO., LTD. (JP) | 2016-07-21 | — | — | US | disclosed |
| US-20090069400-A1 | Indole Sulfonamide Modulators of Progesterone Receptors | ELI LILLY AND COMPANY | 2009-03-12 | — | — | US | disclosed |
| WO-2009008552-A1 | 8-ARYL-4-ALKYLPYRROLO[2,3,4-DE]QUINOLIN-5(4H)-ONE AND 8-ARYL-4-ALKYL-4,5-DIHYDROPYRROLO[2,3,4-DE]QUINOLIN-5-OL DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2009-01-15 | — | — | WO | disclosed |
| US-7365078-B2 | Triaza-cyclopenta[cd]indene derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2008-04-29 | — | — | US | disclosed |
| US-20070270588-A1 | Pyrrolopyrimidine Derivatives | TAISHO PHARMACEUTICAL CO., LTD. | 2007-11-22 | — | — | US | disclosed |
| US-20070270588-A1 | Pyrrolopyrimidine Derivatives | TAISHO PHARMACEUTICAL CO., LTD. | 2007-11-22 | — | — | US | disclosed |
| WO-2007093366-A1 | NOVEL AMINOALCOHOL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | SANOFI-AVENTIS (DE) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007093364-A1 | AZACYCLYL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | SANOFI-AVENTIS (DE) | 2007-08-23 | — | — | WO | disclosed |
| EP-1818325-A2 | 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | SCHERING CORPORATION (US) | 2007-08-15 | — | — | EP | disclosed |
| US-20070060602-A1 | Triaza-cyclopenta [cd] indene derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2007-03-15 | — | — | US | disclosed |
| EP-1704149-B1 | TRIAZA-CYCLOPENTA[CD]INDENE DERIVATIVES | TAISHO PHARMACEUTICAL CO LTD (JP) | 2007-03-07 | — | — | EP | disclosed |